Robert Lehman
Direttore/Membro del Consiglio presso EOM PHARMACEUTICALS HOLDINGS, INC.
Profilo
Robert W.
Lehman is currently a Director at EOM Pharmaceuticals Holdings, Inc. He previously served as an Independent Director at ImmunoCellular Therapeutics Ltd.
and as a Senior Partner at Ernst & Young LLP from 1995 to 2021.
He also briefly served as the Chief Financial Officer at Western Asset Mortgage Capital Corp.
from 2022 to 2023.
Lehman received his undergraduate degree from Queens College.
Posizioni attive di Robert Lehman
Società | Posizione | Inizio |
---|---|---|
EOM PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/04/2022 |
Precedenti posizioni note di Robert Lehman
Società | Posizione | Fine |
---|---|---|
WESN ASSEPAR | Direttore Finanziario/CFO | 06/12/2023 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2021 |
EOM PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | - |
Formazione di Robert Lehman
Queens College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
EOM PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Aziende private | 3 |
---|---|
Western Asset Mortgage Capital Corp.
Western Asset Mortgage Capital Corp. Real Estate Investment TrustsFinance Western Asset Mortgage Capital Corp. operates as a real estate investment trust, which engages in the management of a diversified portfolio of assets. It focuses on investing in financing, and managing real estate related securities, whole loans, and other financial assets. The company was founded on June 3, 2009 and is headquartered in Los Angeles, CA. | Finance |
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
- Borsa valori
- Insiders
- Robert Lehman